MVP ASX Chart
Snapshot
Medical Developments International Limited (MVP) is a Company engaged in delivering emergency medical solutions. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine and for analgesia during short surgical procedures.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2026 YTD | |
| 1 Year | |
| vs Sector (1yr) | -38.73% |
| vs ASX 200 (1yr) | -40.64% |
Announcements
Corporate Overview
Corporate Details
| Head Office | Scoresby VIC 3179 |
| Website | www.medicaldev.com |
| Registry | Computershare |
| Auditor | Deloitte Touche Tohmatsu |
| Date Listed | 15 Dec 2003 |
Upcoming Calendar (Forecasted)
| Date | Event |
|---|---|
| 12/11/2026 | AGM |
| 18/02/2027 | Report (Interim) |
| 19/08/2027 | Report (Prelim) |
| 08/10/2027 | Report (Annual) |
Former Company Names
- Medical Developments International Ltd has no former company names.
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
| Key Data | |
|---|---|
| DPS(TTM) | $0.00 |
| Gross DPS(TTM) | $0.00 |
| Dividend yield |
|
| Gross yield |
|
| Payout Ratio | 0% |
| DRP | Yes |
| DRP Features | -- |
Directors & Management
Directors
Management
Director Transactions
MVP directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of MVP directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
| Name | Last Notice | Total Shares | Shares Held (%) |
|---|---|---|---|
| Regal Funds Management Pty Ltd | 13/08/2026 | 8,906,690 | 7.91 |
| Payne Media Pty Ltd | 26/10/2026 | 8,500,080 | 7.55 |
| Jencay Capital Pty Limited | 29/05/2026 | 7,189,115 | 6.38 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
| Date | Name | Bought | Previous % | New % |
|---|---|---|---|---|
| 26-10-26 | Payne Media Pty Ltd | 1,399,698 | 6.30 | 7.55 |
| 30-06-26 | Payne Media Pty Ltd | 1,166,869 | 5.27 | 6.30 |
| 02-06-26 | Payne Media Pty Ltd | 5,933,513 | -- | 5.27 |
| 29-05-26 | Jencay Capital Pty Limited | 1,132,411 | 5.38 | 6.38 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
| Date | Name | Sold | Previous % | New % |
|---|---|---|---|---|
| 13-08-26 | Regal Funds Management Pty Ltd | 1,389,535 | 9.14 | 7.91 |
| 14-04-26 | Regal Funds Management Pty Ltd | 321,759 | 10.16 | 9.14 |
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2025 | $0.55 | 30 June |
| 2024 | $0.405 | 28 June |
| 2023 | $0.775 | 30 June |
| 2022 | $1.46 | 30 June |
| 2021 | $4.50 | 30 June |
| 2020 | $6.98 | 30 June |
| 2019 | $5.30 | 28 June |
| 2018 | $5.80 | 29 June |
| 2017 | $4.95 | 30 June |
| 2016 | $6.10 | 30 June |
| 2015 | $2.68 | 30 June |
| 2014 | $1.32 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.